Brian Jahns
Corporate Officer/Principal bei GLOBAL HEALTH CLINICS LTD.
Profil
Brian E.
Jahns is currently the Head-Wonder Scientific Division at Global Health Clinics Ltd.
and the Chief Operating Officer at Sauvie, Inc. Previously, he worked as the Senior VP-Commercial & Business Development at Trillium Therapeutics ULC, Vice President-Product Strategy at Hoffmann-La Roche Ltd., and Vice President-Global Marketing at ZYUS Life Sciences, Inc. He also served as the Chief Business Officer at Entheon Biomedical Corp.
from 2021 to 2022.
Jahns received his undergraduate and doctorate degrees from Wayne State University (Michigan).
Aktive Positionen von Brian Jahns
| Unternehmen | Position | Beginn |
|---|---|---|
| GLOBAL HEALTH CLINICS LTD. | Corporate Officer/Principal | 29.04.2021 |
Ehemalige bekannte Positionen von Brian Jahns
| Unternehmen | Position | Ende |
|---|---|---|
| ENTHEON BIOMEDICAL CORP. | Corporate Officer/Principal | 01.10.2022 |
| TRILLIUM THERAPEUTICS | Corporate Officer/Principal | 31.12.2019 |
ZYUS Life Sciences, Inc.
 ZYUS Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Zyus Life Sciences, Inc. operates as a life sciences company. It?s focused on the global development and commercialization of phyto-therapeutics, including cannabinoid and protein-based formulations. The firm offers pharmaceutical-grade phyto-therapeutics, forging new pathways in medicine, cannabinoids and extraction technology. The company was founded by Brent Zettl on April 3, 2018 and is headquartered in Saskatoon, Canada. | Vertrieb & Marketing | - |
Hoffmann-La Roche Ltd.
 Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology Part of Roche Holding AG, Hoffmann-La Roche Ltd. is a Canadian pharmaceutical company that manufactures drugs. The private company is based in Mississauga, Canada. | Corporate Officer/Principal | - |
Ausbildung von Brian Jahns
| Wayne State University (Michigan) | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ENTHEON BIOMEDICAL CORP. | Health Technology |
| GLOBAL HEALTH CLINICS LTD. | Health Services |
| Private Unternehmen | 3 |
|---|---|
Trillium Therapeutics ULC
 Trillium Therapeutics ULC BiotechnologyHealth Technology Trillium Therapeutics, Inc. is a clinical stage immuno-oncology company, which engages in the research and development of therapies for the treatment of cancer. It offers clinical programs, TTI-621 and TTI-622, target CD47, a signal that cancer cells frequently use to evade the immune system. The company was founded on March 31, 2004 and is headquartered in Mississauga, Canada. | Health Technology |
Hoffmann-La Roche Ltd.
Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology Part of Roche Holding AG, Hoffmann-La Roche Ltd. is a Canadian pharmaceutical company that manufactures drugs. The private company is based in Mississauga, Canada. | Health Technology |
ZYUS Life Sciences, Inc.
ZYUS Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Zyus Life Sciences, Inc. operates as a life sciences company. It?s focused on the global development and commercialization of phyto-therapeutics, including cannabinoid and protein-based formulations. The firm offers pharmaceutical-grade phyto-therapeutics, forging new pathways in medicine, cannabinoids and extraction technology. The company was founded by Brent Zettl on April 3, 2018 and is headquartered in Saskatoon, Canada. | Health Technology |
